GlassScriptPrepare for your visit
Jamie A Brown
Internal Medicine · Cape Coral, FL · NPI 1992440838
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$697.00
in general payments reported to CMS, 2019-2025 · $697 in 2025
The $697 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Otsuka America Pharmaceutical, INC. $132.38
- Novo Nordisk INC $72.16
- Bayer Healthcare Pharmaceuticals INC. $71.27
- Lilly USA, LLC $52.34
- Abbvie INC. $50.57
- Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $45.57
Drugs and devices associated with these payments
Rexulti Kerendia Ozempic Zepbound Mounjaro Caplyta Veozah Trelegy Ellipta Leqvio Korlym Vraylar Vyepti
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Jamie Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11897882/jamie-a-brown